Position in EXEL
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$23,324,097
+$17,444,736 QoQ
Shares Held
428,673
+212.7% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#82
of 756 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names. EXEL ranks #22 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in EXEL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,324,097 | 428,673 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $5,879,361 | 137,080 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $6,304,551 | 143,841 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $29,249,238 | 708,214 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $27,502,702 | 623,927 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $27,043,863 | 732,499 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $7,389,702 | 221,913 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $28,839,740 | 1,111,358 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $38,204,123 | 1,700,228 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $41,921,465 | 1,766,602 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $46,767,137 | 1,949,443 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $50,657,127 | 2,318,404 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $109,556,120 | 5,732,921 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $66,332,956 | 3,417,463 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $32,654,344 | 2,035,807 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $32,141,789 | 2,049,859 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $38,988,989 | 1,872,670 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $4,160,942 | 183,544 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $5,632,214 | 308,108 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $333,842 | 15,792 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $6,409,650 | 351,792 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $7,946,981 | 351,792 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $44,320,741 | 2,208,308 | Shares | Sole | 2021-02-01 | |
| 2020-06-30 | $3,921,207 | 165,173 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||